Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Invested Capital: 2012-2025

Historic Invested Capital for Ascendis Pharma A (ASND) over the last 11 years, with Sep 2025 value amounting to $1.3 million.

  • Ascendis Pharma A's Invested Capital rose 101.26% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 101.26%. This contributed to the annual value of $812.7 million for FY2024, which is 51.51% up from last year.
  • Latest data reveals that Ascendis Pharma A reported Invested Capital of $1.3 million as of Q3 2025, which was up 100.63% from -$212.3 million recorded in Q2 2025.
  • Over the past 5 years, Ascendis Pharma A's Invested Capital peaked at $1.2 billion during Q3 2021, and registered a low of -$345.8 million during Q2 2024.
  • Moreover, its 3-year median value for Invested Capital was $88,542 (2023), whereas its average is $36.0 million.
  • Within the past 5 years, the most significant YoY rise in Ascendis Pharma A's Invested Capital was 736.34% (2024), while the steepest drop was 385,086.79% (2024).
  • Ascendis Pharma A's Invested Capital (Quarterly) stood at $1.1 billion in 2021, then plummeted by 30.38% to $787.4 million in 2022, then plummeted by 31.87% to $536.4 million in 2023, then soared by 49.59% to $802.4 million in 2024, then spiked by 101.26% to $1.3 million in 2025.
  • Its Invested Capital stands at $1.3 million for Q3 2025, versus -$212.3 million for Q2 2025 and -$199.7 million for Q1 2025.